​

Eyenovia (EYEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EYEN Stock Rating

Eyenovia stock's rating consensus is Hold, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (33.33%), 4 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 6 0 4 2 Strong Sell Sell Hold Buy Strong Buy

EYEN Price Target Upside V Benchmarks

TypeNameUpside
StockEyenovia-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.67$2.67$2.67
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25--1--1
May, 25--2--2
Apr, 25--2--2
Mar, 25--2--2
Feb, 25--2--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 18, 2024H.C. WainwrightMarket Performdowngrade

Financial Forecast

EPS Forecast

Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.49$-0.66-----
Avg Forecast$-0.85$-0.68$-0.62$-0.46$-0.36$-0.16$0.05
High Forecast$-0.28$-0.67$-0.59$-0.40$-0.25$-0.11$0.06
Low Forecast$-1.36$-0.69$-0.64$-0.52$-0.47$-0.21$0.04
Surprise %-42.35%-2.94%-----

Revenue Forecast

$0 $15M $30M $45M $60M $75M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$14.00M$3.79K$57.34K----
Avg Forecast$4.00M$425.00K$1.63M$5.64M$16.99M$37.46M$60.40M
High Forecast$5.85M$522.78K$2.62M$7.75M$20.90M$46.08M$74.29M
Low Forecast$1.95M$327.22K$611.76K$3.53M$13.08M$28.84M$46.50M
Surprise %250.00%-99.11%-96.47%----

Net Income Forecast

$-60M $-47M $-34M $-21M $-8M $5M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-12.99M$-27.26M$-49.82M----
Avg Forecast$-34.88M$-27.96M$-25.23M$-18.88M$-14.77M$-6.57M$2.05M
High Forecast$-11.68M$-27.54M$-24.17M$-16.57M$-10.35M$-4.60M$2.67M
Low Forecast$-55.84M$-28.38M$-26.29M$-21.18M$-19.19M$-8.53M$1.44M
Surprise %-62.75%-2.49%97.47%----

EYEN Forecast FAQ

Is Eyenovia stock a buy?

Eyenovia stock has a consensus rating of Hold, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Eyenovia is a neutral investment for most analysts.

What is Eyenovia's price target?

Eyenovia's price target, set by 6 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.67.

How does Eyenovia stock forecast compare to its benchmarks?

Eyenovia's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Eyenovia over the past three months?

  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Eyenovia’s EPS forecast?

Eyenovia's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.46, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-0.36 in 2026, $-0.16 in 2027, and $0.05 in 2028.

What is Eyenovia’s revenue forecast?

Eyenovia's average annual revenue forecast for its fiscal year ending in December 2025 is $5.64M, reflecting a 9733.26% increase from the reported $57.34K in 2024. The forecast for 2026 is $16.99M, followed by $37.46M for 2027, and $60.4M for 2028.

What is Eyenovia’s net income forecast?

Eyenovia's net income forecast for the fiscal year ending in December 2025 stands at $-18.875M, representing a -62.11% decrease from the reported $-49.818M in 2024. Projections indicate $-14.772M in 2026, $-6.565M in 2027, and $2.05M in 2028.